216 related articles for article (PubMed ID: 35893619)
1. Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics.
Abdallah HM; El-Halawany AM; Darwish KM; Algandaby MM; Mohamed GA; Ibrahim SRM; Koshak AE; Elhady SS; Fadil SA; Alqarni AA; Abdel-Naim AB; Elfaky MA
Plants (Basel); 2022 Jul; 11(15):. PubMed ID: 35893619
[TBL] [Abstract][Full Text] [Related]
2. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
3. In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.
Shahhamzehei N; Abdelfatah S; Efferth T
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337106
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of aframomum melegueta against severe acute respiratory syndrome coronaviruses type 1 and 2.
Mahoney O; Melo C; Lockhart A; Cornejal N; Alsaidi S; Wu Q; Simon J; Juliani R; Zydowsky TM; Priano C; Koroch A; Fernández Romero JA
S Afr J Bot; 2022 May; 146():735-739. PubMed ID: 34955582
[TBL] [Abstract][Full Text] [Related]
5. In vitro Anti SARS-CoV-2 Activity and Docking Analysis of
Elhusseiny SM; El-Mahdy TS; Elleboudy NS; Yahia IS; Farag MMS; Ismail NSM; Yassien MA; Aboshanab KM
Infect Drug Resist; 2022; 15():3459-3475. PubMed ID: 35813084
[TBL] [Abstract][Full Text] [Related]
6. Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.
Omotuyi IO; Nash O; Ajiboye BO; Olumekun VO; Oyinloye BE; Osuntokun OT; Olonisakin A; Ajayi AO; Olusanya O; Akomolafe FS; Adelakun N
Phytother Res; 2021 Feb; 35(2):908-919. PubMed ID: 32964551
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches.
Abdallah HM; El-Halawany AM; Sirwi A; El-Araby AM; Mohamed GA; Ibrahim SRM; Koshak AE; Asfour HZ; Awan ZA; A Elfaky M
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806331
[TBL] [Abstract][Full Text] [Related]
8. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
[TBL] [Abstract][Full Text] [Related]
9. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
10. Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 M
Zhang M; Liu L; Zhao Y; Cao Y; Zhu Y; Han L; Yang Q; Wang Y; Wang C; Zhang H; Wang Y; Zhang J
Chin Med; 2023 Aug; 18(1):94. PubMed ID: 37528477
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
12. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
13. Computational guided identification of potential leads from
Zothantluanga JH; Gogoi N; Shakya A; Chetia D; Lalthanzara H
Futur J Pharm Sci; 2021; 7(1):201. PubMed ID: 34660817
[TBL] [Abstract][Full Text] [Related]
14. Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from
Al-Karmalawy AA; Alnajjar R; Elmaaty AA; Binjubair FA; Al-Rashood ST; Mansour BS; Elkamhawy A; Eldehna WM; Mansour KA
J Biomol Struct Dyn; 2023 Jul; ():1-13. PubMed ID: 37505066
[TBL] [Abstract][Full Text] [Related]
15. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.
Andrianov AM; Kornoushenko YV; Karpenko AD; Bosko IP; Tuzikov AV
J Biomol Struct Dyn; 2021 Sep; 39(15):5779-5791. PubMed ID: 32662333
[TBL] [Abstract][Full Text] [Related]
16. Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms.
Malebari AM; E A Ahmed H; Ihmaid SK; Omar AM; Muhammad YA; Althagfan SS; Aljuhani N; A A El-Sayed AA; Halawa AH; El-Tahir HM; Turkistani SA; Almaghrabi M; K B Aljohani A; El-Agrody AM; Abulkhair HS
Bioorg Chem; 2023 Jan; 130():106255. PubMed ID: 36403336
[TBL] [Abstract][Full Text] [Related]
17. Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease:
Nutho B; Wilasluck P; Deetanya P; Wangkanont K; Arsakhant P; Saeeng R; Rungrotmongkol T
Comput Struct Biotechnol J; 2022; 20():2784-2797. PubMed ID: 35677603
[TBL] [Abstract][Full Text] [Related]
18.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus.
Zhang Y; Gao H; Hu X; Wang Q; Zhong F; Zhou X; Lin C; Yang Y; Wei J; Du W; Huang H; Zhou H; He W; Zhang H; Zhang Y; McCormick PJ; Fu J; Wang D; Fu Y; Lu X; Zhang T; Duan J; Qin B; Jiang H; Luo J; Zhang Y; Chen Q; Luo Q; Cheng L; Zhang Z; Zhang J; Li J
J Virol; 2022 Jan; 96(1):e0125321. PubMed ID: 34586857
[TBL] [Abstract][Full Text] [Related]
20. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
